Apple is selling a watch whose headline health feature may not work where you live, and the company says so in its own documentation.
Hypertension notifications arrived with the Apple Watch Series 9 generation. They analyze the optical heart sensor for patterns of chronic high blood pressure and warn you across 30-day evaluation windows. They work on the Series 9 or later and the Ultra 2 or later.
They may not work on the Series 12 or Ultra 4.
What Apple Says
Under the requirements for hypertension notifications, Apple's support page includes this warning:
Hypertension Notifications might not be available on Apple Watch Series 12 or Apple Watch Ultra 4 in your region, as additional regulatory clearances for the feature for these models are in process.
Apple's watchOS feature availability documentation carries the same footnote. The affected group is 33 countries and regions, including Canada, Australia, India, Brazil, Singapore, Japan, Taiwan, South Africa, South Korea and the UAE.
Countries not carrying that footnote are unaffected. That covers the United States, the United Kingdom and all EU countries.
The Upgrade Trap
Here is why this is more than a launch-timing annoyance.
Because the feature is supported on the Series 9 and later, plenty of people are using hypertension notifications right now on watches that are one, two or three generations old. If one of those people lives in Canada or Australia or Japan, and upgrades to a Series 12, the feature they currently have may disappear.
Apple's own reporting makes this explicit: users who receive these notifications today may lose the option when moving to the Series 12 or Ultra 4 until regulatory clearance is granted.
So the scenario is a reader in Toronto who buys the new flagship watch, trades in a Series 10 on which hypertension alerts work, and ends up with a more capable watch that cannot do that one thing. Apple has not hidden this. It is in the support documentation. But it is not stamped on the product page, and it runs against the assumption people make about a newer model.
Why New Sensors Broke It
The regulatory gap is the direct result of a hardware improvement, which makes it an unusually honest kind of delay.
The Series 12 and Ultra 4 introduced a revamped Health Sensing System with new optical and electrical heart sensors. Per the reporting on the change:
- The ECG electrodes cover a larger surface area for better skin contact during readings
- The photodiodes were redesigned into a ring layout to capture light more efficiently
- Larger, power-efficient green LEDs let the watch measure heart rate every five seconds all day
- HRV is now measured as often as every five minutes
- Real-time heart rate appears in an updated Heart Rate app, and the Exercise and Move Activity rings are more accurate
Changing the sensors means the algorithm is running on different hardware, which means the regulatory clearances that covered the old sensors do not automatically carry over. The feature is not delayed because Apple de-prioritized it. It is delayed because Apple improved the hardware underneath it.
That is also the reason it should come back. This is a paperwork queue, not a technical failure.
What the Feature Does, for Anyone Reading This Cold
Hypertension notifications are not a blood pressure measurement, and Apple is careful about that framing. The watch looks for patterns in your heart data over rolling 30-day periods, starting from the day you enable the feature.
To turn them on you need an iPhone 11 or later on current iOS, Wrist Detection enabled, and you must be 22 or older, not pregnant, and not previously diagnosed with hypertension. You enable them in the Health app under Health Checklist, where you confirm your age and diagnosis status.
If you get a notification, Apple prompts you to set up a Blood Pressure Log and to take measurements with a third-party blood pressure cuff over seven days, then discuss the results with a clinician. The watch flags a pattern. The cuff and your doctor confirm whether it is real.
When It Is Expected Back
Reporting out of India points to local availability arriving next year for that market and roughly 33 others, pending the clearances currently in process.
Apple has not published a date, and it will not be a single date anyway. Regulatory approval in Canada, Japan, Brazil and the rest arrives market by market, so the footnote will shrink in patches rather than disappear all at once.
What to Do If You Are Deciding
If you live in one of the affected regions and hypertension notifications are something you actively use:
- Check the availability status for your specific country on Apple's watchOS feature availability page rather than assuming from the headline count
- Do not trade in a Series 9, 10 or 11 yet if that feature is the reason you would upgrade. The old watch does something the new one currently cannot
- Know that everything else improves. The new sensing hardware is what created the gap, and the heart rate, HRV and ECG work on the Series 12 and Ultra 4 is the best Apple has shipped
For buyers in the United States, the UK and the EU, none of this applies. The feature works on the new watches there.
Bottom Line
Apple's flagship watch ships with a documented gap in 33 countries: hypertension notifications, a feature supported on the Series 9 and newer, may not work on the Series 12 or Ultra 4 while clearances for the new sensor hardware are processed. People who currently have the feature on an older watch can lose it by upgrading, in Canada, Australia, Japan, India and 29 other markets, until those approvals land.
The feature should return. The mistake worth avoiding is trading in a watch that has it before it does.
Sources: Apple's support documentation for hypertension notifications on Apple Watch including the regional availability warning, Apple's watchOS feature availability status page, Apple's published requirements and setup steps for hypertension notifications, and reporting from MacRumors, MacObserver and The Economic Times on the 33 affected countries and the expected clearance timeline.